286 related articles for article (PubMed ID: 1976463)
1. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
[TBL] [Abstract][Full Text] [Related]
2. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
3. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
4. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
5. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
6. T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules.
Turco MC; Alfinito F; De Felice M; Lamberti A; Ferrone S; Venuta S
Blood; 1991 Oct; 78(8):2045-52. PubMed ID: 1680497
[TBL] [Abstract][Full Text] [Related]
7. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
[TBL] [Abstract][Full Text] [Related]
8. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
[TBL] [Abstract][Full Text] [Related]
9. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
10. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
11. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
12. Antigen-independent pathways of T-cell activation are functional in human immature thymocytes.
Poggi A; Zocchi MR
Int J Clin Lab Res; 1992; 21(4):304-9. PubMed ID: 1375518
[TBL] [Abstract][Full Text] [Related]
13. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
Lin CS; Boltz RC; Siekierka JJ; Sigal NH
Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
[TBL] [Abstract][Full Text] [Related]
14. Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions.
Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
Scand J Immunol; 1988 Sep; 28(3):277-84. PubMed ID: 2461580
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
16. Accessory signals in T-T cell interactions between antigen- and alloantigen-specific, human memory T cells generated in vitro.
Odum N; Ryder LP; Georgsen J; Jakobsen BK; Geisler C; Møller J; Morling N; Dickmeiss E; Svejgaard A
Scand J Immunol; 1990 Jun; 31(6):717-28. PubMed ID: 2162555
[TBL] [Abstract][Full Text] [Related]
17. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
18. CD1+ thymocytes proliferate and give rise to functional cells after stimulation with monoclonal antibodies recognizing CD3, CD2 or CD28 surface molecules.
Zocchi MR; Marelli F; Poggi A
Cell Immunol; 1990 Sep; 129(2):394-403. PubMed ID: 1696526
[TBL] [Abstract][Full Text] [Related]
19. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]